Tag: HNSCC patients

Simple blood tests could predict immunotherapy effectiveness

Written by
Dr George Laliotis and his team predict the response of head and neck squamous cell carcinoma (HNSCC) patients to immunotherapy using precision-medicine techniques.

Despite the extensive use of immunotherapy in patients suffering from head and neck squamous cell carcinoma, this therapy has significant limitations. Not everyone responds to treatment and current therapies can have serious adverse side effects. When working at the Johns Hopkins School of Medicine, Sidney Kimmel Comprehensive Cancer Center, USA, Dr George Laliotis and his team discovered that biochemical factors, measured […]

Read More… from Simple blood tests could predict immunotherapy effectiveness